Dashboard
Manage Tickers

NTLA Intellia Therapeutics, Inc.

Nasdaq intelliatx.com


$ 24.99 $ -0.16 (-0.64 %)    

Friday, 17-Oct-2025 19:36:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 24.75
$ 24.31
$ 23.99 x 491
$ 25.15 x 200
$ 23.99 - $ 25.18
$ 5.90 - $ 26.99
3,835,359
na
2.66B
$ 2.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 10-31-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-01-2018 03-31-2018 10-Q
31 03-14-2018 12-31-2017 10-K
32 10-31-2017 09-30-2017 10-Q
33 08-01-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 03-14-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 06-03-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dell-select-medical-century-aluminum-and-other-big-stocks-moving-higher-on-wednesday
Dell, Select Medical, Century Aluminum And...
10/08/2025 14:39:06

what-analysts-are-saying-about-intellia-therapeutics-stock
What Analysts Are Saying About Intellia Th...
10/06/2025 12:01:15

jmp-securities-upgrades-intellia-therapeutics-to-market-outperform-announces-33-price-target
JMP Securities Upgrades Intellia Therapeut...
10/06/2025 11:01:46

JMP Securities analyst Silvan Tuerkcan upgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Perform to Market Outperform...

acuity-lithium-americas-rezolve-ai-aes-and-other-big-stocks-moving-higher-on-wednesday
Acuity, Lithium Americas, Rezolve AI, AES ...
10/01/2025 13:57:33

intellia-highlights-clinical-improvements-with-one-time-dose-of-experimental-drug
Intellia Highlights Clinical Improvements ...
09/25/2025 17:57:31

Intellia Therapeutics Inc. (NASDAQ: NTLA) on Thursday released longer-term follow-up data from the ongoing Phase 1 study of inv...

intellia-therapeutics-presents-longer-term-follow-up-data-from-ongoing-phase-1-study-of-investigational-nex-z-for-treatment-of-hereditary-attrv-pn-in-oral-session-at-international-attr-amyloidosis-annual-meeting
Intellia Therapeutics Presents Longer-Term...
09/25/2025 13:54:57

One dose of nex-z led to rapid, deep and durable TTR reductions, with mean reductions of at least 90% from baseline sustained t...

intellia-therapeutics-to-present-longer-term-data-from-ongoing-phase-1-trial-of-investigational-nex-z-for-treatment-of-hereditary-attrv-pn-at-international-attr-amyloidosis-meeting-for-patients-and-doctors
Intellia Therapeutics To Present Longer-Te...
09/22/2025 11:36:09

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine wi...

jmp-securities-reiterates-market-perform-on-intellia-therapeuticsto-market-perform
JMP Securities Reiterates Market Perform o...
09/19/2025 12:40:46

JMP Securities analyst Silvan Tuerkcan reiterates Intellia Therapeutics (NASDAQ:NTLA) from Market Perform to Market Perform.

tesla-to-rally-more-than-31-here-are-10-top-analyst-forecasts-for-friday
Tesla To Rally More Than 31%? Here Are 10 ...
09/19/2025 12:22:31

expert-outlook-intellia-therapeutics-through-the-eyes-of-5-analysts
Expert Outlook: Intellia Therapeutics Thro...
09/19/2025 12:00:36

hc-wainwright--co-maintains-buy-on-intellia-therapeutics-raises-price-target-to-30
HC Wainwright & Co. Maintains Buy on Intel...
09/19/2025 11:39:13

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and raises the p...

russell-2000-hits-all-time-highs-8-stocks-power-small-cap-comeback
Russell 2000 Hits All-Time Highs: 8 Stocks...
09/18/2025 19:08:11

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since ta...

intellia-therapeutics-shares-are-ripping-higher-heres-why
Intellia Therapeutics Shares Are Ripping H...
09/18/2025 18:33:37

Intellia Therapeutics Inc (NASDAQ:NTLA) shares are soaring on Thursday after the company completed enrollment in its crucial Ph...

my-top-biotech-stock-picks-and-portfolio-strategy-for-the-next-3-10-years
My Top Biotech Stock Picks And Portfolio S...
09/18/2025 17:10:48

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 17:06:02

radian-group-intel-nanobiotix-crowdstrike-and-other-big-stocks-moving-higher-on-thursday
Radian Group, Intel, Nanobiotix, CrowdStri...
09/18/2025 14:19:12

intellia-therapeutics-completes-enrollment-in-global-phase-3-haelo-study-of-lonvoguran-ziclumeran-for-hae-treatment-topline-data-expected-in-h1-of-2026
Intellia Therapeutics Completes Enrollment...
09/18/2025 11:35:46

Completed patient enrollment within nine months with nearly half enrolled from the U.S.Expect to report Phase 3 topline data in...

demystifying-intellia-therapeutics-insights-from-9-analyst-reviews
Demystifying Intellia Therapeutics: Insigh...
08/11/2025 18:00:56

walt-disney-to-rally-more-than-25-here-are-10-top-analyst-forecasts-for-monday
Walt Disney To Rally More Than 25%? Here A...
08/11/2025 12:48:56

chardan-capital-maintains-buy-on-intellia-therapeutics-lowers-price-target-to-60
Chardan Capital Maintains Buy on Intellia ...
08/11/2025 11:25:33

Chardan Capital analyst Geulah Livshits maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the price target...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION